Inventor
KNIGHT STEVEN DAVID
US34 patents
⚠️ This page may combine multiple inventors who share the name “KNIGHT STEVEN DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM CORP
8 patentsUS7041676B2May 9, 2006
Compounds, compositions, and methods
SMITHKLINE BEECHAM CORP87 citations98
US7214800B2May 8, 2007
Compounds, compositions, and methods
SMITHKLINE BEECHAM CORP21 citations92
US7166595B2Jan 23, 2007
Compounds, methods and compositions
SMITHKLINE BEECHAM CORP25 citations92
US7038048B2May 2, 2006
3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
SMITHKLINE BEECHAM CORP32 citations92
US6924376B2Aug 2, 2005
Compounds, compositions and methods
SMITHKLINE BEECHAM CORP22 citations92
US6544992B1Apr 8, 2003
Urotensin-II receptor antagonists
SMITHKLINE BEECHAM CORP22 citations92
US6949538B2Sep 27, 2005
Compounds, compositions, and methods
SMITHKLINE BEECHAM CORP4 citations63
US6514970B1Feb 4, 2003
Urotensin-II receptor antagonists
SMITHKLINE BEECHAM CORP6 citations60
CYTOKINETICS INC
8 patentsUS7528137B2May 5, 2009
Compounds, compositions, and methods
CYTOKINETICS INC19 citations92
US7332498B2Feb 19, 2008
Modulation of KSP kinesin activity with heterocyclic-fused pyrimidinone derivatives
CYTOKINETICS INC19 citations92
US7208487B2Apr 24, 2007
Compounds, compositions and methods
CYTOKINETICS INC39 citations92
US7629477B2Dec 8, 2009
Compounds, compositions and methods
CYTOKINETICS INC5 citations73
US7491746B2Feb 17, 2009
Compounds, compositions and methods
CYTOKINETICS INC5 citations73
US7482343B2Jan 27, 2009
Compounds, methods and compositions
CYTOKINETICS INC3 citations63
US7919524B2Apr 5, 2011
Compounds, compositions and methods
CYTOKINETICS INC0 citations52
US7476743B2Jan 13, 2009
Compounds, compositions, and methods
CYTOKINETICS INC0 citations52
GLAXOSMITHKLINE LLC
6 patentsUS8785433B2Jul 22, 2014
Quinoline derivatives as PI3 kinase inhibitors
GLAXOSMITHKLINE LLC9 citations84
US9562041B2Feb 7, 2017
Enhancer of zeste homolog 2 inhibitors
GLAXOSMITHKLINE LLC13 citations83
US9382234B2Jul 5, 2016
Enhancer of Zeste Homolog 2 inhibitors
GLAXOSMITHKLINE LLC8 citations82
US9956210B2May 1, 2018
Enhancer of zeste homolog 2 inhibitors
GLAXOSMITHKLINE LLC2 citations72
US9402836B2Aug 2, 2016
Indoles
GLAXOSMITHKLINE LLC2 citations60
US10478426B2Nov 19, 2019
Enhancer of Zeste Homolog 2 inhibitors
GLAXOSMITHKLINE LLC0 citations51
KNIGHT STEVEN DAVID
3 patentsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
3 patentsUS9556157B2Jan 31, 2017
Enhancer of zeste homolog 2 inhibitors
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD8 citations83
US9505745B2Nov 29, 2016
Enhancer of zeste homolog 2 inhibitors
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD11 citations82
US9790212B2Oct 17, 2017
Enhancer of zeste homolog 2 inhibitors
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD2 citations71